Compositions and methods for producing isoprene free of C5 hydrocarbons under decoupling conditions and/or safe operating ranges
US-9777294-B2 · Oct 3, 2017 · US
US10774345B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10774345-B2 |
| Application number | US-201715677335-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 15, 2017 |
| Priority date | Jul 2, 2008 |
| Publication date | Sep 15, 2020 |
| Grant date | Sep 15, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention features methods for producing isoprene from cultured cells wherein the cells in the stationary phase. The invention also provides compositions that include these cultured cells and/or increased amount of isoprene. The invention also provides for systems that include a non-flammable concentration of isoprene in the gas phase. Additionally, the invention provides isoprene compositions, such as compositions with increased amount of isoprene or increased purity.
Opening claim text (preview).
What is claimed is: 1. A biologically produced composition comprising: (a) greater than 2 mg of isoprene; and (b) 2-methyl-3-buten-2-ol, and ethyl acetate, wherein the amount of at least one of the 2-methyl-3-buten-2-ol and ethyl acetate relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 2. The composition of claim 1 , wherein at least a portion of the isoprene is in the gas phase. 3. The composition of claim 1 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 90% (w/w), between about 0.01% to about 80% (w/w), between about 0.01% to about 50% (w/w), between about 0.01% to about 20% (w/w), between about 0.01% to about 10% (w/w), between about 0.02% to about 50% (w/w), between about 0.05% to about 50% (w/w), between about 0.1% to about 50% (w/w), or between about 0.1% to about 20% (w/w). 4. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 90% (w/w). 5. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 80% (w/w). 6. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 50% (w/w). 7. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 20% (w/w). 8. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 10% (w/w). 9. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.02% to about 50% (w/w). 10. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.05% to about 50% (w/w). 11. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.1% to about 50% (w/w). 12. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.1% to about 20% (w/w). 13. The composition of claim 1 , further comprising (c) one or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the one or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 14. The composition of claim 1 , further comprising (c) two or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the two or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 15. The composition of claim 1 , further comprising (c) three or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the three or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 16. The composition of claim 1 , further comprising (c) four or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the four or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 17. The composition of claim 1 , further comprising (c) five or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the five or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 18. The composition of claim 1 , further comprising (c) six or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the six or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 19. The composition of claim 1 , further comprising (c) seven or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3
Bacteria; Culture media therefor · CPC title
acyclic {(C12P5/007 takes precedence)} · CPC title
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title
for Bacillus · CPC title
Genes encoding for enzymes or proenzymes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.